Combination of Bempegaldesleukin and Anti-CTLA-4 Prevents Metastatic Dissemination After Primary Resection or Radiotherapy in a Preclinical Model of Non-Small Cell Lung Cancer

Surgical resection or hypo-fractionated radiation therapy (RT) in early-stage non-small cell lung cancer (NSCLC) achieves local tumor control, but metastatic relapse remains a challenge. We hypothesized that immunotherapy with anti-CTLA-4 and bempegaldesleukin (BEMPEG; NKTR-214), a CD122-preferentia...

Descripción completa

Detalles Bibliográficos
Autores principales: Bates, Amber M., Brown, Ryan J., Pieper, Alexander A., Zangl, Luke M., Arthur, Ian, Carlson, Peter M., Le, Trang, Sosa, Gustavo A., Clark, Paul A., Sriramaneni, Raghava N., Kim, KyungMann, Patel, Ravi B., Morris, Zachary S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8083981/
https://www.ncbi.nlm.nih.gov/pubmed/33937052
http://dx.doi.org/10.3389/fonc.2021.645352

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8083981/
https://www.ncbi.nlm.nih.gov/pubmed/33937052
http://dx.doi.org/10.3389/fonc.2021.645352

Ejemplares similares